Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy, safety, and tolerability of canagliflozin in adults with type 2 diabetes has completed. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Canagliflozin (canagliflozin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Diabetes Mellitus, Type II, Diabetes Mellitus, Non Insulin Dependent | Phase 2 | Status: COMPLETED | Results posted: 2013-05-17